Latest News
Concept Foundation remembers Dr. Gordon Perkin
Dr. Gordon Perkin, a Canadian physician who was a global health visionary ahead of his time, passed away on 21 August 2020. In the early years of his professional career, Dr. Perkin was engaged in leadership roles in the pharmaceutical industry, at the Planned...
Optimal intrapartum care in the twenty-first century
Introducing a new series on intrapartum care in the journal Best Practice and Research in Obstetrics and Gynaecology, Concept CF Executive Director A. Metin Gülmezoglu discusses the importance of respectful care and how care during childbirth needs to be...
We Need More Pharmaceutical R&D to Improve Maternal Health
Since the beginning of the Millennium Development Goals period and stretching out to the current Sustainable Development Goals period, pharmaceutical research and development (R&D) in maternal health has not been a global public health priority. During this...
WHO Prequalifies a 2nd generic DMPA product with Concept Foundation support
Concept Foundation is happy to announce that Incepta Pharmaceuticals (Bangladesh) has been awarded WHO Prequalification of their intramuscular (IM) depot medroxyprogesterone acetate (DMPA) 150 mg/ml product.
WHO has prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
WHO has just prequalified a combination mifepristone-misoprostol (combipack) for medical abortion
A third quality assured, generic DMPA-IM product available for procurement
A third quality assured, generic DMPA-IM contraceptive product available for procurement
From Concept Foundation: July 2019
New beginnings @ConceptFNDN When I started working on the heat stable carbetocin project in 2012 at the Special Programme of Research on Human Reproduction (HRP), a public private partnership between WHO/HRP, Ferring Pharmaceuticals and MSD for Mothers I was...
Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director
Concept Foundation announces A. Metin Gülmezoglu as its new Executive Director
Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results released
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial results have been released, finally providing long awaited answers to questions about the relationship between DMPA, the Implant and the Copper IUD and risk of HIV transmission in women.
World Preeclampsia Day – Access to quality magnesium sulfate to reduce maternal mortality
Access to quality magnesium sulfate and implementation of guidelines can help reduce maternal deaths due to preeclampsia. When a mother dies, the impact of her death reaches much further than the individual tragedy. It affects the life and health of the family,...
